TY - JOUR
T1 - Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease
AU - Pugliese, Nicola
AU - Wai-Sun Wong, Vincent
AU - Schattenberg, Jörn M
AU - Romero-Gomez, Manuel
AU - Sebastiani, Giada
AU - Aghemo, Alessio
AU - Castera, Laurent
AU - Hassan, Cesare
AU - Manousou, Pinelopi
AU - Miele, Luca
AU - Peck, Raquel
AU - Petta, Salvatore
AU - Valenti, Luca
AU - Younossi, Zobair M
PY - 2024
Y1 - 2024
N2 - : Nonalcoholic fatty liver disease (NAFLD) is an increasing global health problem and is expected to become the leading indication for liver transplantation.1 There are no approved NAFLD-specific pharmacotherapies, and lifestyle modification is the primary recommended therapy.2 Innovative approaches to facilitate the implementation and long-term maintenance of lifestyle changes are needed to address the challenging and complex nature of the management of NAFLD, which recently was renamed as metabolic dysfunction-associated steatotic liver disease, to overcome the limitations and stigma of the previous name.3,4 Artificial intelligence (AI)-powered chatbots have been shown to provide effective personalized support and education to patients, with the potential to complement health care resources. The OpenAI Foundation's AI chatbot, Chat Generative Pretrained Transformer (ChatGPT), has attracted worldwide attention for its remarkable performance in question-answer tasks.5-7 This study evaluated the accuracy, completeness, and comprehensiveness of chatGPT's responses to NAFLD-related questions, with the aim of assessing its performance in addressing patients' queries about the disease and lifestyle behaviors.
AB - : Nonalcoholic fatty liver disease (NAFLD) is an increasing global health problem and is expected to become the leading indication for liver transplantation.1 There are no approved NAFLD-specific pharmacotherapies, and lifestyle modification is the primary recommended therapy.2 Innovative approaches to facilitate the implementation and long-term maintenance of lifestyle changes are needed to address the challenging and complex nature of the management of NAFLD, which recently was renamed as metabolic dysfunction-associated steatotic liver disease, to overcome the limitations and stigma of the previous name.3,4 Artificial intelligence (AI)-powered chatbots have been shown to provide effective personalized support and education to patients, with the potential to complement health care resources. The OpenAI Foundation's AI chatbot, Chat Generative Pretrained Transformer (ChatGPT), has attracted worldwide attention for its remarkable performance in question-answer tasks.5-7 This study evaluated the accuracy, completeness, and comprehensiveness of chatGPT's responses to NAFLD-related questions, with the aim of assessing its performance in addressing patients' queries about the disease and lifestyle behaviors.
KW - Non-alcoholic Fatty Liver Disease/ therapy
KW - Non-alcoholic Fatty Liver Disease/ therapy
UR - https://publicatt.unicatt.it/handle/10807/273477
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85175016596&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85175016596&origin=inward
U2 - 10.1016/j.cgh.2023.08.033
DO - 10.1016/j.cgh.2023.08.033
M3 - Article
SN - 1542-3565
VL - 22
SP - 886
EP - 889
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 4
ER -